Barclays’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-125,200
| Closed | -$12.5M | – | 4993 |
|
|
2024
Q1 | $12.5M | Buy |
+125,200
| New | +$11M | ﹤0.01% | 1238 |
|
|
2021
Q1 | – | Sell |
-500
| Closed | -$50K | – | 4822 |
|
|
2020
Q4 | $50K | Sell |
500
-6,900
| -93% | -$640K | ﹤0.01% | 4398 |
|
|
2020
Q3 | $578K | Hold |
7,400
| – | – | ﹤0.01% | 3126 |
|
|
2020
Q2 | $515K | Sell |
7,400
-19,700
| -73% | -$1.24M | ﹤0.01% | 3318 |
|
|
2020
Q1 | $1.26M | Buy |
27,100
+3,500
| +15% | +$225K | ﹤0.01% | 2722 |
|
|
2019
Q4 | $1.87M | Sell |
23,600
-14,000
| -37% | -$1.08M | ﹤0.01% | 3075 |
|
|
2019
Q3 | $2.78M | Buy |
37,600
+33,100
| +736% | +$2.38M | ﹤0.01% | 2473 |
|
|
2019
Q2 | $350K | Buy |
4,500
+2,800
| +165% | +$213K | ﹤0.01% | 4640 |
|
|
2019
Q1 | $129K | Sell |
1,700
-6,400
| -79% | -$509K | ﹤0.01% | 5162 |
|
|
2018
Q4 | $592K | Buy |
8,100
+3,900
| +93% | +$311K | ﹤0.01% | 3654 |
|
|
2018
Q3 | $402K | Sell |
4,200
-1,700
| -29% | -$169K | ﹤0.01% | 4452 |
|
|
2018
Q2 | $590K | Sell |
5,900
-6,400
| -52% | -$676K | ﹤0.01% | 3791 |
|
|
2018
Q1 | $1.3M | Sell |
12,300
-15,200
| -55% | -$1.54M | ﹤0.01% | 2912 |
|
|
2017
Q4 | $2.55M | Buy |
27,500
+700
| +3% | +$63.6K | ﹤0.01% | 2222 |
|
|
2017
Q3 | $2.42M | Sell |
26,800
-13,300
| -33% | -$1.13M | ﹤0.01% | 2155 |
|
|
2017
Q2 | $3.37M | Buy |
40,100
+35,400
| +753% | +$2.85M | ﹤0.01% | 1785 |
|
|
2017
Q1 | $380K | Sell |
4,700
-3,100
| -40% | -$244K | ﹤0.01% | 3679 |
|
|
2016
Q4 | $587K | Sell |
7,800
-12,300
| -61% | -$888K | ﹤0.01% | 3224 |
|
|
2016
Q3 | $1.36M | Sell |
20,100
-1,700
| -8% | -$114K | ﹤0.01% | 2339 |
|
|
2016
Q2 | $1.48M | Sell |
21,800
-54,700
| -72% | -$4.02M | ﹤0.01% | 2261 |
|
|
2016
Q1 | $5.51M | Buy |
76,500
+25,300
| +49% | +$1.66M | 0.01% | 1107 |
|
|
2015
Q4 | $3.43M | Buy |
51,200
+13,600
| +36% | +$952K | ﹤0.01% | 1587 |
|
|
2015
Q3 | $2.41M | Sell |
37,600
-12,900
| -26% | -$952K | ﹤0.01% | 1956 |
|
|
2015
Q2 | $4.09M | Buy |
50,500
+12,600
| +33% | +$972K | ﹤0.01% | 1662 |
|
|
2015
Q1 | $2.62M | Buy |
37,900
+2,400
| +7% | +$173K | ﹤0.01% | 2067 |
|
|
2014
Q4 | $2.66M | Sell |
35,500
-9,200
| -21% | -$727K | ﹤0.01% | 2267 |
|
|
2014
Q3 | $3.58M | Buy |
44,700
+18,300
| +69% | +$1.53M | ﹤0.01% | 2094 |
|
|
2014
Q2 | $2.3M | Sell |
26,400
-3,800
| -13% | -$330K | ﹤0.01% | 2458 |
|
|
2014
Q1 | $2.6M | Sell |
30,200
-3,400
| -10% | -$279K | ﹤0.01% | 2289 |
|
|
2013
Q4 | $2.69M | Sell |
33,600
-47,700
| -59% | -$3.7M | ﹤0.01% | 2369 |
|
|
2013
Q3 | $6.26M | Buy |
81,300
+57,400
| +240% | +$4.42M | 0.01% | 1499 |
|
|
2013
Q2 | $1.67M | Buy |
+23,900
| New | +$1.67M | ﹤0.01% | 2743 |
|
Other funds holding EMN
VPM
VCM
Barclays's EMN Position: Q1 2026 in Review
Barclays reduced its Eastman Chemical (EMN) stake by 86% in Q1 2026, selling an estimated $6.47M and leaving 14,917 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2676.
Barclays first reported a position in EMN in Q2 2013 and has held it in 52 quarters since. The position peaked at $52.2M in Q4 2019. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.
- Barclays held 14,917 shares of Eastman Chemical worth $1.14M as of Q1 2026.
- Barclays sold 89,722 Eastman Chemical shares in Q1 2026, an estimated $6.47M.
- Eastman Chemical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2676 holding.
- Barclays first reported a position in Eastman Chemical in Q2 2013 and has held it in 52 quarters since.
- Barclays's Eastman Chemical position peaked at $52.2M in Q4 2019.
- 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.